Due Date Accommodations for Investigators Responding to the West Africa Ebola Outbreak

The Ebola outbreak in West Africa is the largest Ebola outbreak in history. NIH appreciates the humanitarian assistance being provided by NIH-supported program directors and principal investigators who travel to West Africa to participate in emergency response activities. As described in NIH Guide Notice NOT-OD-15-010, we have made accommodations to provide additional time for application submission and grant-related reporting for these investigators. …. Continue reading

Email this to someoneTweet about this on TwitterShare on FacebookShare on LinkedInShare on Google+Pin on PinterestPrint this page

Retention Rates for First-Time R01 Awardees

We have seen increased interest in the biomedical workforce by Congress and especially by our community. From our end we’ve in particular observed heightened attention to how the dynamics of the workforce impact researchers in the early stages of their careers. So the topic definitely deserves our continued attention and I thought in light of this it’d be a good time to share some of NIH’s analyses on one specific aspect of this that my office has been closely examining. …. Continue reading

Email this to someoneTweet about this on TwitterShare on FacebookShare on LinkedInShare on Google+Pin on PinterestPrint this page

New NIH Awards to Enhance Diversity in the Scientific Workforce

Today marks an important step forward for NIH’s support of a diverse scientific workforce. NIH has announced the awardees of unique, targeted programs for developing new approaches to engage researchers from underrepresented backgrounds and for preparing them to thrive in scientific careers. …. Continue reading

Email this to someoneTweet about this on TwitterShare on FacebookShare on LinkedInShare on Google+Pin on PinterestPrint this page

A Pause in Funding Certain Types of Gain-of-Function Research

The White House announced today that U.S. government agencies will institute a pause in the funding of new “gain-of-function” research on influenza, SARS, and MERS viruses that could increase the pathogenicity or transmissibility to mammals …. During this funding pause, the government will carry out a deliberative process to assess the risks and benefits of such studies and will develop a new Federal policy regarding the funding of this research. …. Continue reading

Email this to someoneTweet about this on TwitterShare on FacebookShare on LinkedInShare on Google+Pin on PinterestPrint this page